Discounted Cash Flow Rating
Buy
Return on Equity Rating
Buy
Debt to Equity Rating
Buy
Price to Earnings Rating
Strong Sell
Analyst Rating
Neutral
Wall Street Data Solutions Rating
Neutral
B
Corcept Therapeutics Inc. (CORT)
Pharmaceutical Preparations
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
149 COMMONWEALTH DRIVE
MENLO PARK, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
04/14/2004
Market Cap
3,575,716,240
Shares Outstanding
103,080,000
Weighted SO
103,081,357
Total Employees
N/A
Upcoming Earnings
08/07/2024
Beta
0.4380
Last Div
0.0000
Range
20.84-39.75
Chg
-0.7200
Avg Vol
1067674
Mkt Cap
3575716240
Exch
NASDAQ
Country
US
Phone
650 327 3270
DCF Diff
-60.7023
DCF
94.6823
Div Yield
0.0000
P/S
6.2775
EV Multiple
26.7422
P/FV
5.9182
Div Yield %
0.0000
P/E
28.0914
PEG
2.9719
Payout
0.0000
Current Ratio
5.5667
Quick Ratio
5.4838
Cash Ratio
1.2763
DSO
35.9720
DIO
355.1742
Op Cycle
391.1462
DPO
828.7682
CCC
-437.6220
Gross Margin
0.9849
Op Margin
0.2246
Pretax Margin
0.2630
Net Margin
0.2205
Eff Tax Rate
0.1589
ROA
0.1758
ROE
0.2379
ROCE
0.2084
NI/EBT
0.8386
EBT/EBIT
1.1707
EBIT/Rev
0.2246
Debt Ratio
0.0079
D/E
0.0095
LT Debt/Cap
0.0093
Total Debt/Cap
0.0094
Int Coverage
35.7269
CF/Debt
21.8264
Equity Multi
1.1984
Rec Turnover
10.1468
Pay Turnover
0.4404
Inv Turnover
1.0277
FA Turnover
79.5989
Asset Turnover
0.7972
OCF/Share
1.1999
FCF/Share
1.1955
Cash/Share
4.5885
OCF/Sales
0.2172
FCF/OCF
0.9963
CF Coverage
21.8264
ST Coverage
2812.1364
CapEx Coverage
273.1435
Div&CapEx Cov
273.1435
P/BV
5.9182
P/B
5.9182
P/S
6.2775
P/E
28.0914
P/FCF
29.0046
P/OCF
28.5184
P/CF
28.5184
PEG
2.9719
P/S
6.2775
EV Multiple
26.7422
P/FV
5.9182
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ 135.41M | ▲ 146.81M |
Cost Of Revenue | XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 1.88M | ▲ 2.54M |
Gross Profit | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ 133.53M | ▲ 144.27M |
Gross Profit Ratio | X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ 0.99 | ▼ 0.98 |
Research And Development Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 54.71M | ▲ 58.51M |
General And Administrative Expenses | X | X | X | X | X | 0.00 | 0.00 |
Selling And Marketing Expenses | X | X | X | X | X | 0.00 | 0.00 |
Selling General And Administrative Expenses | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 47.15M | ▲ 56.27M |
Other Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ 0.00 | 0.00 |
Operating Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 101.86M | ▲ 114.77M |
Cost And Expenses | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 103.74M | ▲ 117.31M |
Interest Income | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ XXXXX | ▲ XXXXXXX | ▲ 5.14M | ▲ 5.49M |
Interest Expense | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ XXXXX | ▲ XXXXXXX | ▲ 3.58M | ▼ 0.00 |
Depreciation And Amortization | XXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ 630.00K | ▼ 120.00K |
Ebitda | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 32.30M | ▼ 29.62M |
Ebitda Ratio | X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ 0.24 | ▼ 0.20 |
Operating Income | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 31.67M | ▼ 29.50M |
Operating Income Ratio | X.XXXXXXXXX | ▲ X.XXXXXXXXX | ▼ X.XXXXXXXXX | ▲ X.XXXXXXXXX | ▼ X.XXXXXXXXX | ▲ 0.23 | ▼ 0.20 |
Total Other Income Expenses Net | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ -XXXXX | ▲ XXXXXXX | ▲ 5.14M | ▲ 5.49M |
Income Before Tax | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 36.81M | ▼ 34.99M |
Income Before Tax Ratio | X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ 0.27 | ▼ 0.24 |
Income Tax Expense | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ 5.45M | ▲ 7.23M |
Net Income | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 31.36M | ▼ 27.76M |
Net Income Ratio | X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ X.XXXXXXXXXX | ▼ X.XXXXXXXXXX | ▲ 0.23 | ▼ 0.19 |
Eps | X.XX | ▲ X.XX | ▼ X.XX | ▲ X.XX | ▼ X.XX | ▲ 0.30 | ▼ 0.27 |
Eps Diluted | X.XX | ▲ X.XX | ▼ X.XX | ▲ X.XX | ▼ X.XX | ▲ 0.28 | ▼ 0.25 |
Weighted Average Shs Out | XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 102.46M | ▲ 102.79M |
Weighted Average Shs Out Dil | XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▼ XXXXXXXXX | ▼ 110.89M | ▼ 109.92M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 135.55M | ▲ 149.75M |
Short Term Investments | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 232.67M | ▲ 261.01M |
Cash And Short Term Investments | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 368.22M | ▲ 410.76M |
Net Receivables | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 55.12M | ▲ 63.52M |
Inventory | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ 7.73M | ▼ 7.19M |
Other Current Assets | XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 27.56M | ▼ 21.90M |
Total Current Assets | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 458.64M | ▲ 503.37M |
Property Plant Equipment Net | XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ 315.00K | ▼ 188.00K |
Goodwill | X | X | X | X | X | 0.00 | 0.00 |
Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Goodwill And Intangible Assets | X | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -XXXXXXXXX | ▲ X | 0.00 | ▼ -1.00 |
Long Term Investments | X | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXX | ▲ 57.18M | ▼ 40.28M |
Tax Assets | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 90.61M | ▲ 97.87M |
Other Non Current Assets | XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 14.79M | ▼ 14.23M |
Total Non Current Assets | XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 162.88M | ▼ 152.57M |
Other Assets | X | X | X | X | X | 0.00 | ▲ 1.00 |
Total Assets | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 621.52M | ▲ 655.94M |
Account Payables | XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▲ 17.40M | ▼ 12.56M |
Short Term Debt | X | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ 151.00K | ▼ 76.00K |
Tax Payables | XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ XXXXX | ▲ 2.89M | ▲ 13.46M |
Deferred Revenue | X | X | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ X | ▲ 86.30M | ▼ 10.87M |
Other Current Liabilities | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ 654.00K | ▲ 73.70M |
Total Current Liabilities | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▲ 104.51M | ▼ 97.20M |
Long Term Debt | X | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ 0.00 | 0.00 |
Deferred Revenue Non Current | X | X | X | X | X | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Liabilities | XXXXXX | ▲ XXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▲ 10.31M | ▲ 10.87M |
Total Non Current Liabilities | XXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▲ 10.31M | ▲ 10.87M |
Other Liabilities | -XXXXXX | ▼ -XXXXXXX | ▲ X | X | ▼ -XXXXXXX | ▲ 0.00 | 0.00 |
Capital Lease Obligations | X | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ 151.00K | ▼ 76.00K |
Total Liabilities | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ 114.81M | ▼ 108.07M |
Preferred Stock | X | X | X | X | X | 0.00 | 0.00 |
Common Stock | XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ 133.00K | 133.00K |
Retained Earnings | -XXXXXXXXX | ▲ -XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 402.53M | ▲ 430.29M |
Accumulated Other Comprehensive Income Loss | -XXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ 609.00K | ▼ 258.00K |
Other Total Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 103.44M | ▲ 117.19M |
Total Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 506.71M | ▲ 547.86M |
Total Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 506.71M | ▲ 547.86M |
Total Liabilities And Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 621.52M | ▲ 655.94M |
Minority Interest | X | X | X | X | X | 0.00 | 0.00 |
Total Liabilities And Total Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 621.52M | ▲ 655.94M |
Total Investments | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXXX | ▲ XXXXXXXXX | ▼ 289.85M | ▲ 301.29M |
Total Debt | X | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ 151.00K | ▼ 76.00K |
Net Debt | -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▲ -XXXXXXXXX | ▼ -XXXXXXXXX | ▲ -135.40M | ▼ -149.67M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 31.36M | ▼ 27.51M |
Depreciation And Amortization | XXXXX | ▲ XXXXXX | ▲ XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ 630.00K | ▼ 120.00K |
Deferred Income Tax | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXXX | ▼ -XXXXXXX | ▲ -3.67M | ▼ -7.16M |
Stock Based Compensation | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 13.07M | ▲ 13.25M |
Change In Working Capital | -XXXXXXX | ▲ XXXXXXX | ▼ -XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▼ -32.30M | ▲ -7.41M |
Accounts Receivables | XXXXXXX | ▲ XXXXXXX | ▼ -XXXXXXX | ▲ -XXXXXXX | ▼ -XXXXXXX | ▼ -6.50M | ▲ -6.40M |
Inventory | -XXXXXXX | ▲ -XXXXXX | ▼ -XXXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▲ 329.00K | ▲ 983.00K |
Accounts Payables | -XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ 995.00K | ▼ -4.86M |
Other Working Capital | -XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ -27.12M | ▲ 2.86M |
Other Non Cash Items | -XXXXXX | ▲ -XXXXXX | ▲ XXXXXX | ▲ XXXXXXX | ▼ -XXXXXX | ▼ -3.20M | ▲ 21.21M |
Net Cash Provided By Operating Activities | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 5.89M | ▲ 23.76M |
Investments In Property Plant And Equipment | -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ -XXXXX | ▲ -XXXXX | ▲ 0.00 | 0.00 |
Acquisitions Net | X | X | X | X | ▲ XXXXXXXX | ▼ 0.00 | 0.00 |
Purchases Of Investments | -XXXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ X | ▼ -XXXXXXXX | ▲ -29.90M | ▼ -77.88M |
Sales Maturities Of Investments | XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▼ 47.00M | ▲ 68.86M |
Other Investing Activities | X | X | X | X | ▼ -XXXXXXXX | ▲ 17.10M | ▼ -9.01M |
Net Cash Used For Investing Activities | -XXXXXXX | ▼ -XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ -XXXXXXXX | ▲ 17.10M | ▼ -9.01M |
Debt Repayment | X | X | X | X | ▼ -XXXXXX | ▼ -1.22M | ▲ 0.00 |
Common Stock Issued | XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ XXXXXXX | ▲ 4.40M | ▼ 1.69M |
Common Stock Repurchased | -XXXXXXXX | ▲ X | ▼ -XXXXXXX | ▼ -XXXXXXXXX | ▲ -XXXXXX | ▼ -145.43M | ▲ -476.00K |
Dividends Paid | X | X | X | X | X | 0.00 | 0.00 |
Other Financing Activities | -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXX | ▲ 144.22M | ▼ -1.76M |
Net Cash Used Provided By Financing Activities | -XXXXXXXX | ▲ -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXXXXX | ▲ -XXXXX | ▲ 766.00K | ▼ -543.00K |
Effect Of Forex Changes On Cash | X | X | X | X | X | ▼ -91.86M | ▲ 0.00 |
Net Change In Cash | XXXXXXX | ▼ -XXXXXXXX | ▲ XXXXXXXX | ▼ -XXXXXXXX | ▲ XXXXXXXX | ▲ 23.75M | ▼ 14.20M |
Cash At End Of Period | XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 135.55M | ▲ 149.75M |
Cash At Beginning Of Period | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 111.80M | ▲ 135.55M |
Operating Cash Flow | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 5.89M | ▲ 23.76M |
Capital Expenditure | -XXXXXX | ▼ -XXXXXX | ▼ -XXXXXX | ▲ -XXXXX | ▲ -XXXXX | ▲ 0.00 | 0.00 |
Free Cash Flow | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▼ 5.89M | ▲ 23.76M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Upgrade To Get Access
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Dicta eveniet ex illo maxime minima numquam quibusdam reprehenderit temporibus vel, voluptatum? Delectus eos eveniet id iusto necessitatibus, neque porro unde voluptatibus. Aut blanditiis commodi, iste iure laborum pariatur temporibus. Atque distinctio dolore, doloremque eaque eius harum inventore laudantium quibusdam recusandae voluptatibus.